EORTC abstracts at ESMO 2018
15 Oct 2018
Results from a number of EORTC trials will be presented at ESMO2018 Congress in Munich, please see below the title and presenters of the presentations:
Oral Presentation
- An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23)- EORTC QLQ-BR45
Presentation Number: 193O
Tumour Group: Quality of Life
Speaker: Vesna Bjelic-Radisic (Germany)
Date: 20.10.2018 – Lecture Time: 11:00 – Location: Hall A2 – Room 18
Poster Discussion
- A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC – the ETOP and EORTC SPLENDOUR trial.
Presentation Number 1385PD
Tumour Group: Lung
Poster Presenter: Solange Peters (Switzerland)
Date: 21.10.2018 – Lecture Time 17:15 – Location: ICM – Room 13
- Health-related quality of life in randomized controlled trials: a systematic review of prognostic significance
Presentation Number: 1540PD
Tumour Group: Quality of Life
Speaker: Justyna Mierzynska (Belgium)
Date: 22.10.2018 – Lecture Time: 16:30 – Location: Hall B3 – Room 21
Poster Display Session
- Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): results from an EORTC led survey
Poster Board Number: 1106P
Tumour Group: Head & Neck
Poster Presenter: Sjoukje Oosting (The Netherlands)
Date: 21.10.2018 – Lecture Time: 13:05 – 13:05 – Location: Hall A3 – Poster Area Networking Hub
- Combined analysis of gene expression profiles in 2 preoperative trials with afatinib and cetuximab in head and neck squamous cell carcinoma
Poster Board Number: 1086P
Tumour Group: Head & Neck
Poster Presenter: Paolo Bossi (Italy)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
- Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: an international randomized double-blind phase 3 trial.
Poster Board Number: 1278P
Tumour Group: Quality of Life
Poster Presenter: Corneel Coens (Belgium)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024